Cencora, Inc. $COR Shares Sold by Deutsche Bank AG

Deutsche Bank AG lowered its position in shares of Cencora, Inc. (NYSE:COR) by 20.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 920,782 shares of the company’s stock after selling 232,362 shares during the period. Deutsche Bank AG owned approximately 0.47% of Cencora worth $310,994,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Oakworth Capital Inc. acquired a new stake in Cencora in the 4th quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new stake in Cencora in the 4th quarter valued at approximately $27,000. Archer Investment Corp increased its holdings in Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. IAG Wealth Partners LLC acquired a new stake in Cencora in the 3rd quarter valued at approximately $30,000. Finally, Caitlin John LLC acquired a new stake in Cencora in the 3rd quarter valued at approximately $31,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Weiss Ratings downgraded shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Wells Fargo & Company dropped their target price on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. Barclays dropped their target price on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday. William Blair assumed coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Finally, Morgan Stanley set a $342.00 target price on shares of Cencora in a report on Friday, May 8th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $374.00.

Cencora Price Performance

Cencora stock opened at $281.48 on Thursday. The stock has a market cap of $54.76 billion, a P/E ratio of 21.59, a price-to-earnings-growth ratio of 1.51 and a beta of 0.59. The company has a fifty day simple moving average of $290.59 and a 200-day simple moving average of $328.55. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The firm had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.Cencora’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period last year, the firm posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Equities analysts expect that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s payout ratio is 18.40%.

Cencora announced that its board has initiated a stock buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s management believes its shares are undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.